Covered recipient · General Payments record
JEANNE MICHELE MAIELLO
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2024
$646.90
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $646.90 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $175.03 | 8 |
| Amgen Inc. | $157.44 | 7 |
| UCB, Inc. | $62.74 | 3 |
| Janssen Biotech, Inc. | $58.50 | 2 |
| Acerta Pharma LLC | $48.45 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $39.07 | 2 |
| Alexion Pharmaceuticals, Inc. | $33.86 | 1 |
| ANI Pharmaceuticals, Inc. | $32.92 | 1 |
| Fresenius Kabi USA, LLC | $20.50 | 1 |
| PFIZER INC. | $18.39 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $646.90 | 28 |
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.81 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107578377 | CMS |
| ABBVIE INC. | $19.38 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107578379 | CMS |
| ABBVIE INC. | $22.44 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107578381 | CMS |
| ABBVIE INC. | $25.27 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107578383 | CMS |
| ABBVIE INC. | $27.73 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107578385 | CMS |
| ABBVIE INC. | $10.30 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107578387 | CMS |
| ABBVIE INC. | $23.50 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107578389 | CMS |
| ABBVIE INC. | $22.60 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107578391 | CMS |
| Alexion Pharmaceuticals, Inc. | $33.86 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094022874 | CMS |
| Amgen Inc. | $33.41 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115892782 | CMS |
| Amgen Inc. | $16.12 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115892788 | CMS |
| Amgen Inc. | $15.39 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115892794 | CMS |
| Amgen Inc. | $11.26 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115892799 | CMS |
| Amgen Inc. | $28.57 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117617668 | CMS |
| Amgen Inc. | $27.13 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115892804 | CMS |
| Amgen Inc. | $25.56 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115892777 | CMS |
| ANI Pharmaceuticals, Inc. | $32.92 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091139004 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.17 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105793444 | CMS |
| AstraZeneca Pharmaceuticals LP | $29.28 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104766788 | CMS |
| Fresenius Kabi USA, LLC | $20.50 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146946261 | CMS |
| Janssen Biotech, Inc. | $23.65 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078489797 | CMS |
| Janssen Biotech, Inc. | $34.85 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078490074 | CMS |
| Novartis Pharmaceuticals Corporation | $14.04 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087156138 | CMS |
| Novartis Pharmaceuticals Corporation | $25.03 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087156154 | CMS |
| PFIZER INC. | $18.39 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131853921 | CMS |
| UCB, Inc. | $14.18 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143256749 | CMS |
| UCB, Inc. | $17.37 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143256754 | CMS |
| UCB, Inc. | $31.19 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143256758 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.